Uploaded August 2026 | Updated November 2026, 4 days ago
"Flowering Time, Genetics & Climate Adaptation in Cannabis" panel discussion at CannMed 2026, covering photoperiod sensing, circadian rhythms, nutrient signaling, and climate-adaptive breeding.
Flowering time determines yield, cannabinoid expression, harvest timing, and regulatory compliance. This panel brings together leading geneticists and plant scientists to examine how genome structure, nutrient signaling, photoperiod sensing, and climate adaptation converge to control floral induction in cannabis.
Panelists explore how genetics, environment, and nutrient status interact to control flowering, including how flowering genes and regulatory regions differ across landraces and hybrids, the role of photoperiod and circadian signaling in floral induction timing, nutrient-driven transcriptional control of flowering and energy allocation, matching genotype to latitude, climate stress, and compliance timelines, and breeding climate-adaptive cultivars that balance yield predictability and cannabinoid expression.
Panelists:
Kevin McKernan (Moderator), CSO & Founder, Medicinal Genomics
Todd Michael, PhD, Research Professor, The Salk Institute for Biological Studies
George Stack, Postdoctoral Scientist, Cornell University / Topcross Genomics
Justine Richard-Giroux, Agr., Research Assistant, Université Laval
Zachary Wise, Director of Cultivation & Genetics, Happy Valley
This panel was part of the CannMed Cultivation Workshop, a program focused on the science of sustainable cannabis production.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
"Flowering Time, Genetics & Climate Adaptation in Cannabis" panel discussion at CannMed 2026, covering photoperiod sensing, circadian rhythms, nutrient signaling, and climate-adaptive breeding.
Flowering time determines yield, cannabinoid expression, harvest timing, and regulatory compliance. This panel brings together leading geneticists and plant scientists to examine how genome structure, nutrient signaling, photoperiod sensing, and climate adaptation converge to control floral induction in cannabis.
Panelists explore how genetics, environment, and nutrient status interact to control flowering, including how flowering genes and regulatory regions differ across landraces and hybrids, the role of photoperiod and circadian signaling in floral induction timing, nutrient-driven transcriptional control of flowering and energy allocation, matching genotype to latitude, climate stress, and compliance timelines, and breeding climate-adaptive cultivars that balance yield predictability and cannabinoid expression.
Panelists:
Kevin McKernan (Moderator), CSO & Founder, Medicinal Genomics
Todd Michael, PhD, Research Professor, The Salk Institute for Biological Studies
George Stack, Postdoctoral Scientist, Cornell University / Topcross Genomics
Justine Richard-Giroux, Agr., Research Assistant, Université Laval
Zachary Wise, Director of Cultivation & Genetics, Happy Valley
This panel was part of the CannMed Cultivation Workshop, a program focused on the science of sustainable cannabis production.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.










![Why Explore Cannabinoids as an Alternative to Sleep Medicine for Children with ASD? - Mohsin Maqbool
Why Explore Cannabinoids as an Alternative to Sleep Medicine for Children with Autism Spectrum Disorder (ASD)?
Dr. Mohsin Maqbool is a pediatric neurologist and sleep specialist based in Dallas–Fort Worth, Texas. His work focuses on the intersection of neurodevelopment, sleep, and cannabinoid therapeutics in autism spectrum disorder. He is particularly interested in how cannabinoid formulations may influence sleep regulation, behavior, and quality of life in children with autism.
At CannMed 26, Mohsin will present “Autism, Sleep, and Medicinal Cannabis: Evaluating 18-Month Efficacy and Safety Outcomes”
During our conversation, we discuss:
- The gaps in current sleep medicine for children with Autism Spectrum Disorder
- Results from Mohsin’s 18-month longitudinal study including improvements to total sleep time, sleep onset and maintenance, and overall quality of sleep
- The method of finding the effective dose for each patient
- Cannabinoids’ effect on the duration of REM sleep and what the daytime implications are
- Thinking of cannabis as a tool to supplement conventional ASD medications and not a replacement
- Future research directions - using wearables and EEG to investigate how cannabinoids affect sleep architecture and brain physiology, as well as using biomarkers to see whether patients are a good candidate for cannabinoid therapies
Thanks to This Episode’s Sponsor: The Society of Cannabis Clinicians
The Society of Cannabis Clinicians is a nonprofit professional association of physicians and other healthcare providers. It provides continuing education—for clinicians, patients, and all concerned about the medical use of cannabis and best practices in clinical care. SCC physicians have been monitoring cannabis use by patients for 20 years and have compiled a wealth of clinical evidence and treatment strategies that will be validated by clinical trials in the years ahead.
To learn more about SCC and to join visit cannabisclinicians.org.
Additional Resources
- Effects of Medical Cannabis Treatment for Autistic Children on Family Accommodation: An Open-Label Mixed-Methods Study - https://pmc.ncbi.nlm.nih.gov/articles/PMC12563248/
- [Book] Cannabis Is Medicine: How Medical Cannabis and CBD Are Healing Everything from Anxiety to Chronic Pain by Dr. Bonni Goldstein - https://www.amazon.com/Cannabis-Medicine-Medical-Healing-Everything/dp/031650078X
- Register for CannMed 26 - https://cannmedevents.com/package-options/
- Meet the CannMed 26 Speakers - https://cannmedevents.com/speakers/
- Review the Podcast - https://podcasts.apple.com/us/podcast/cannmed-coffee-talk/id1504218804
- CannMed Archive - https://cannmedevents.com/cannmed-video-archives/ Why Explore Cannabinoids as an Alternative to Sleep Medicine for Children with ASD? - Mohsin Maqbool](https://i.ytimg.com/vi/icACT6YW4Zg/mqdefault.jpg)